Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy Reports|July 1, 1975
Potential biologic markers in Burkitt's lymphomaT P Waalkes, C W Gehrke, W A Bleyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study GroupP G Steinherz, P Gaynon, D R Miller, et al.Medical and Pediatric Oncology|January 1, 1991
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting featuresP S Gaynon, P G Steinherz, W A Bleyer, et al.Medical and Pediatric Oncology|January 1, 1990
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting featuresP S Gaynon, W A Bleyer, P G Steinherz, et al.Medical and Pediatric Oncology|January 1, 1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group studyW R Balsom, W A Bleyer, L L Robison, et al.Journal of Pediatric Surgery|February 1, 1988
The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study GroupJ T Makley, M Krailo, I J Ertel, et al.Cancer Treatment Reports|November 1, 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapyG H Reaman, P G Steinherz, P S Gaynon, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1988
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193PP S Gaynon, W A Bleyer, P G Steinherz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimenW A Bleyer, P F Coccia, H N Sather, et al.Cancer Research|August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day scheduleP C Adamson, F M Balis, J Miser, et al.Pageof 13